NexgenRx Inc.
NXG.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 212.21% | 464.06% | 137.27% | -5.71% | -96.97% |
| Total Depreciation and Amortization | -5.41% | -5.99% | -3.19% | -5.79% | -3.73% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -83.02% | 7.87% | -39.22% | -58.57% | -135.81% |
| Change in Net Operating Assets | -158.76% | 109.59% | -34.89% | 152.93% | -49.46% |
| Cash from Operations | -81.62% | 56.84% | -18.44% | 181.96% | -46.55% |
| Capital Expenditure | 85.89% | -435.71% | -191.49% | -103.57% | 91.58% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 26.59% | -- | 100.00% | -- |
| Cash from Investing | -24.18% | 11.85% | -855.32% | -103.73% | 91.91% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -53.18% | -39.31% | -19.65% | -1.49% | 42.72% |
| Issuance of Common Stock | 0.00% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 1.63% | 8.88% | -0.41% | -1,166.26% | 92.31% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -341.76% | 14.52% | 242.20% | -643.31% | 102.65% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -94.84% | 8,305.13% | -2.93% | 73.39% | 221.93% |
